SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing significant momentum and volatility as investors react to positive FDA briefing documents regarding its mRNA flu vaccine candidate ahead of a key advisory committee vote. The community is actively debating the stock's long-term growth potential through its expanding oncology and rare disease pipeline, while also tracking high short interest that has fueled speculation of a potential short squeeze.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Churchill Capital Corp XI is trending due to significant institutional accumulation and the building momentum surrounding the Agility Robotics commercialization narrative. Community sentiment remains focused on the potential for a major re-rating as investors compare the firm's strategic industrial partnerships to successful past robotics and infrastructure plays.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is seeing heightened community engagement driven by anticipation of a potential buyout, as investors weigh the impact of recent product approvals and the company's aggressive pipeline development in the GLP-1 adjunct space. While bullish participants point to valuable clinical assets as prime acquisition targets, others remain focused on navigating volatility and debating the impact of management's confrontational regulatory strategy on future valuation.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is currently a focal point for investors debating whether its aggressive acquisition strategy and high short interest signal an impending rebound or further downside following heavy share dilution. The community is sharply divided, with bulls pointing to the company's expanding backlog and defense partnerships, while vocal critics are focused on insider selling and the stock's poor recent performance.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is experiencing significant volatility driven by the market weighing its pivot toward AI-integrated fiber infrastructure against ongoing balance sheet concerns and structural revenue declines. Community sentiment remains deeply divided, with some investors betting on the company's potential to become a critical AI backbone, while others remain skeptical of the long-term turnaround execution.

WorldFinancial

Investors are actively debating the future of World Liberty Financial ($WLFI.X) amid sharp criticism of its performance and vocal community accusations of a potential "rug pull" or grift tied to political branding. While some participants are aggressively calling for a rebound driven by anticipated token burns and supply shocks, others are heavily focused on the significant losses incurred and questioning the project's long-term legitimacy.

Sharplink, Inc. is an institutional-grade Ethereum treasury platform that provides public market investors with exposure to ETH. The platform focuses on Ethereum, which is used in various stablecoin, tokenized real-world asset, and decentralized finance settlement applications. This allows for native yield generation and potential network growth opportunities with ETH. The company is also involved in the online affiliate marketing business. The company was founded in 2019 and is headquartered in Miami, FL.

Sharplink Inc.

SharpLink Gaming Ltd

SharpLink Gaming is trending as investors react to its aggressive Ethereum-focused treasury strategy and recent inclusion in the Russell 2000 and 3000 indexes, which has spurred intense community debate over its long-term viability. While some shareholders view the stock's deep discount to net asset value as a prime accumulation opportunity for the next crypto cycle, others are voicing frustration over sustained downward price pressure and the risks associated with the company's reliance on Ethereum holdings.

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Nuvation Bio Inc - Ordinary Shares - Class A

Nuvation Bio is experiencing significant market volatility surrounding its earnings report as investors weigh the company's Ibtrozi commercial launch against concerns over patient retention in late-line treatments. Community sentiment remains split between long-term optimism regarding a potential buyout catalyst and frustration over recent downward price pressure and insider trading activity.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is facing intense selling pressure as investors grapple with shifting consumer spending, GLP-1 weight-loss drug impacts, and competition from other QSR brands. While the community remains divided between those viewing the pullback as a long-term accumulation opportunity for a defensive dividend payer and those concerned about weakening same-store sales and structural headwinds, the stock's recent volatility has triggered heavy speculation among short-term traders.

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Abeona Therapeutics Inc

Abeona Therapeutics is trending as investors react to the company's shift from development to commercialization, with community discussion centered on the rollout of ZEVASKYN and anticipation for Q1 earnings. The conversation is heavily focused on potential short squeeze dynamics driven by high short interest, institutional accumulation, and the expectation of revenue acceleration through an expanding network of Qualified Treatment Centers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Knightscope (KSCP) Announces Approximately $3.8 Million In New And Recurring Contracts Across Eight Verticals

Knightscope (KSCP) Announces Approximately $3.8 Million In New And Recurring Contracts Across Eight Verticals...

KSCP Rides on Holistic Growth: Should You Stay Invested in the Stock?

Knightscope fuels recurring revenue as AI security robots and blue-light towers gain adoption, while CASE Emergency Systems expands its reach.

Knightscope Announces Nearly $4 Million in New and Recurring Contracts

Knightscope, Inc. (NASDAQ: KSCP), a managed service provider building the nations first Autonomous Security Force (ASF), today announced approximately $3.8 million in new and recurring contracts across eight verticals. The contracts span critical infrastructure, retail and consumer, healthcare and...

Knightscope, Inc. (KSCP) Reports Q1 Loss, Tops Revenue Estimates

Knightscope (KSCP) delivered earnings and revenue surprises of -42.31% and +131.39%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Knightscope Q1 Revenue Up 106% to $6M

Knightscope, Inc. (NASDAQ: KSCP), a managed service provider building the nations first Autonomous Security Force, today reported financial results for the first quarter ended March 31, 2026. This press release features multimedia. View the full release here...

Knightscope, Inc. (KSCP) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Knightscope (KSCP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Knightscope Q1 EPS Boosted by Ascendiant Capital Markets

Knightscope, Inc. (NASDAQ:KSCP - Free Report) - Stock analysts at Ascendiant Capital Markets raised their Q1 2026 earnings per share estimates for shares of Knightscope in a research note issued to investors on Monday, April 13th. Ascendiant Capital Markets analyst E. Woo now forecasts that the comp...

Ascendiant Capital Markets Predicts Knightscope Q1 Earnings

Knightscope, Inc. (NASDAQ:KSCP - Free Report) - Analysts at Ascendiant Capital Markets issued their Q1 2027 EPS estimates for shares of Knightscope in a research note issued to investors on Monday...

Short Interest in Knightscope, Inc. (NASDAQ:KSCP) Increases By 28.3%

Knightscope, Inc. (NASDAQ:KSCP - Get Free Report) saw a significant increase in short interest during the month of March. As of March 31st, there was short interest totaling 1,924,271 shares, an...

Knightscope and Carnegie Mellon University Enter Into Letter Agreement

Knightscope, Inc. (NASDAQ: KSCP), a managed service provider building the nations first Autonomous Security Force, today announced that it has entered into a letter agreement with Carnegie Mellon...

Knightscope, Inc. engages in the provision and development of security technology solutions. Its product portfolio includes the K1 stationary machine, the K3 indoor machine, the K5 outdoor machine, and the K7 multi-terrain four-wheel vehicle. Its machines patrol client sites without the need for remote control to provide a visible, force multiplying, physical security presence to help protect assets, monitor changes in the area, and deter crime. The company was founded by William Santana Li and Stacy Dean Stephens on April 4, 2013 and is headquartered in Sunnyvale, CA.

Knightscope Inc - Ordinary Shares - Class A

Palantir Jumps Into Top 25 Most Valuable Companies List As Stock Hits Record-High After Knightscope Deal 

Equity

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$2.04
Prev Close	$2.07
Open	$2.04
Dividend Yield	0.00%
50-Day Moving Average	$2.60
Beta	1.81
Avg. Volume	594,143.10
PE Ratio	-0.57

52-Week High	$10.14
52-Week Low	$1.78
Market Capitalization	$35.71M
EPS (Annual)	-$4.00
Price to Book	0.98
Revenue Per Employee	$125,944.44

Feed

News

Sentiment

Earnings

Fundamentals

Info

KSCPKnightscope Inc - Ordinary Shares - Class A

Latest KSCP News